Log In
Print
BCIQ
Print
Print this Print this
 

ADI-PEG 20

  Manage Alerts
Collapse Summary General Information
Company Polaris Pharmaceuticals Inc.
DescriptionArginine deiminase (ADI) formulated with polyethylene glycol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today